These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 10082885

  • 1. Modulation of the neuronal nicotinic acetylcholine receptor-channel by the nootropic drug nefiracetam.
    Oyaizu M, Narahashi T.
    Brain Res; 1999 Mar 20; 822(1-2):72-9. PubMed ID: 10082885
    [Abstract] [Full Text] [Related]

  • 2. Nootropic drug modulation of neuronal nicotinic acetylcholine receptors in rat cortical neurons.
    Zhao X, Kuryatov A, Lindstrom JM, Yeh JZ, Narahashi T.
    Mol Pharmacol; 2001 Apr 20; 59(4):674-83. PubMed ID: 11259610
    [Abstract] [Full Text] [Related]

  • 3. Post-stroke dementia. Nootropic drug modulation of neuronal nicotinic acetylcholine receptors.
    Zhao X, Yeh JZ, Narahashi T.
    Ann N Y Acad Sci; 2001 Jun 20; 939():179-86. PubMed ID: 11462769
    [Abstract] [Full Text] [Related]

  • 4. Effects of the nootropic drug nefiracetam on the GABAA receptor-channel complex in dorsal root ganglion neurons.
    Huang CS, Ma JY, Marszalec W, Narahashi T.
    Neuropharmacology; 1996 Jun 20; 35(9-10):1251-61. PubMed ID: 9014140
    [Abstract] [Full Text] [Related]

  • 5. [Facilitatory actions of the cognitive enhancer nefiracetam on neuronal Ca2+ channels and nicotinic ACh receptors: their intracellular signal transduction pathways].
    Yoshii M, Nishizaki T, Watabe S.
    Nihon Yakurigaku Zasshi; 1998 Oct 20; 112 Suppl 1():41P-43P. PubMed ID: 10190131
    [Abstract] [Full Text] [Related]

  • 6. Nefiracetam modulates acetylcholine receptor currents via two different signal transduction pathways.
    Nishizaki T, Matsuoka T, Nomura T, Sumikawa K, Shiotani T, Watabe S, Yoshii M.
    Mol Pharmacol; 1998 Jan 20; 53(1):1-5. PubMed ID: 9443926
    [Abstract] [Full Text] [Related]

  • 7. Nefiracetam facilitates hippocampal neurotransmission by a mechanism independent of the piracetam and aniracetam action.
    Nomura T, Nishizaki T.
    Brain Res; 2000 Jul 07; 870(1-2):157-62. PubMed ID: 10869513
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A 'long-term-potentiation-like' facilitation of hippocampal synaptic transmission induced by the nootropic nefiracetam.
    Nishizaki T, Matsuoka T, Nomura T, Matsuyama S, Watabe S, Shiotani T, Yoshii M.
    Brain Res; 1999 May 01; 826(2):281-8. PubMed ID: 10224305
    [Abstract] [Full Text] [Related]

  • 11. Presynaptic nicotinic acetylcholine receptors as a functional target of nefiracetam in inducing a long-lasting facilitation of hippocampal neurotransmission.
    Nishizaki T, Matsuoka T, Nomura T, Kondoh T, Watabe S, Shiotani T, Yoshii M.
    Alzheimer Dis Assoc Disord; 2000 May 01; 14 Suppl 1():S82-94. PubMed ID: 10850735
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Enhancement of neuronal calcium channel currents by the nootropic agent, nefiracetam (DM-9384), in NG108-15 cells.
    Yoshii M, Watabe S.
    Brain Res; 1994 Apr 11; 642(1-2):123-31. PubMed ID: 8032872
    [Abstract] [Full Text] [Related]

  • 14. Unique mechanism of action of Alzheimer's drugs on brain nicotinic acetylcholine receptors and NMDA receptors.
    Narahashi T, Marszalec W, Moriguchi S, Yeh JZ, Zhao X.
    Life Sci; 2003 Dec 05; 74(2-3):281-91. PubMed ID: 14607256
    [Abstract] [Full Text] [Related]

  • 15. The anti-dementia drug nefiracetam facilitates hippocampal synaptic transmission by functionally targeting presynaptic nicotinic ACh receptors.
    Nishizaki T, Nomura T, Matuoka T, Kondoh T, Enikolopov G, Sumikawa K, Watabe S, Shiotani T, Yoshii M.
    Brain Res Mol Brain Res; 2000 Aug 14; 80(1):53-62. PubMed ID: 11039729
    [Abstract] [Full Text] [Related]

  • 16. Nefiracetam potentiates N-methyl-D-aspartate (NMDA) receptor function via protein kinase C activation and reduces magnesium block of NMDA receptor.
    Moriguchi S, Shioda N, Maejima H, Zhao X, Marszalec W, Yeh JZ, Fukunaga K, Narahashi T.
    Mol Pharmacol; 2007 Feb 14; 71(2):580-7. PubMed ID: 17095583
    [Abstract] [Full Text] [Related]

  • 17. Nonselective cationic currents activated by acetylcholine in swine tracheal smooth muscle cells.
    Yamashita T, Kokubun S.
    Can J Physiol Pharmacol; 1999 Oct 14; 77(10):796-805. PubMed ID: 10588484
    [Abstract] [Full Text] [Related]

  • 18. Cellular mechanism of action of cognitive enhancers: effects of nefiracetam on neuronal Ca2+ channels.
    Yoshii M, Watabe S, Murashima YL, Nukada T, Shiotani T.
    Alzheimer Dis Assoc Disord; 2000 Oct 14; 14 Suppl 1():S95-102. PubMed ID: 10850736
    [Abstract] [Full Text] [Related]

  • 19. Lysophosphatidic acid potentiates ACh receptor currents by G-protein-mediated activation of protein kinase C.
    Nishizaki T, Sumikawa K.
    Brain Res Mol Brain Res; 1997 Oct 15; 50(1-2):121-6. PubMed ID: 9406926
    [Abstract] [Full Text] [Related]

  • 20. Dynorphins directly inhibit neuronal nicotinic acetylcholine receptors in PC12 cells.
    Itoh H, Andoh T, Watanabe I, Sasaki T, Kamiya Y, Okumura F.
    Eur J Neurosci; 2000 Apr 15; 12(4):1253-62. PubMed ID: 10762354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.